 |
 |
| Home · Program · FAQ · Apply · Contact |
|
|||||
|
|
|
|
||
|
|
|
|
||
CH 638 - Special Topics Course on Industrial Chemistry
Time & Location: Spring Term, 2008 - MWF 11 am to noon
in
Gilbert 324 |
| April 7-11 |
Dr. Neal Anderson Anderson's Process Solutions Jacksonville, OR |
(1)
Fundamental Differences
between Chemical Research in Academia & the Pharmaceutical
Industry; (2) Case Studies in
the Preparation of Captopril, Fosinopril
Sodium, and other APIs; (3)
Case Studies in the Preparation of
Irbesartan, an Anti-Migraine Candidate, and other APIs |
| April 21-25 | Dr. Rick Poniaszek Senior Director of Chemical Development Gilead Sciences Foster Lake, CA |
Process Research and Development, antiviral programs, AIDS candidates, HIV protease inhibitors |
| May 5-9 | Dr. Mike Garst Vice President of Chemical Sciences Allergan Inc. Irvine, CA |
(1) Discovery of Lumigan - A Drug
for Glaucoma; (2) Next
Generation Proton Pump Inhibitors; (3)
Recent Adventures in Imidazole Chemistry |
| May 19-23 |
Dr. Tae-Seong Kim
Amgen Inc.
Thousand Oaks, CA
|
(1) A
Novel Class of Non-covalent
Cathepsins Inhibitors; (2)
Structure-based Design of VEGFR2 Inhibitors; (3) Going after
Tumor Metastasis: Discovery of AMG 458 |
| June 2-6 |
Dr.
Kevin Hodgetts Project Leader Neurogen Corporation Branford, CT |
(1) The
design, synthesis and optimization of novel heterocyclic CRF-1 receptor
antagonists for the treatment of depression and anxiety; (2) From arylureas to biarylamides
to aminoquinazolines: The evolution of TRPV1 antagonists for the
treatment of pain; (3) The
discovery of MCH-1 receptor antagonists for the treatment of obesity |
|
|